Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists

To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort

(2015) Serena Granziera et al.   Internal and Emergency Medicine

Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs

(2015) Freek W A Verheugt et al.   LANCET

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people

(2013) Olivier Hanon et al.   Archives of Cardiovascular Diseases

Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin

(2013) S. Burgess et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement

(2013) Elaine M. Hylek   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Bleeding Risk Prediction Models in Atrial Fibrillation

(2013) Isac C. Thomas et al.   Current Cardiology Reports

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

(2012) Vanessa Roldán et al.   CHEST

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

(2012) Pilar Gallego et al.   Circulation-Arrhythmia and Electrophysiology

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation

(2012) Gregory Y. H. Lip et al.   Circulation-Arrhythmia and Electrophysiology

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009

(2012) A. C. E. Scowcroft et al.   HEART

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation

(2012) Stavros Apostolakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outcomes and Safety of Antithrombotic Treatment in Patients Aged 80 Years or Older With Nonvalvular Atrial Fibrillation

(2011) Martín Ruiz Ortiz et al.   AMERICAN JOURNAL OF CARDIOLOGY

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

(2011) Daniela Poli et al.   CIRCULATION

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

(2011) J. B. OLESEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Statistical methods for assessment of added usefulness of new biomarkers

(2010) Michael J. Pencina et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice

(2008) Ahmed H. Abdelhafiz et al.   American Journal Geriatric Pharmacotherapy